Stock Information
Relay Therapeutics Inc (RLAY)
Ticker Symbol: RLAY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,778.29 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.6129
Revenue (TTM): $0.09 M
Dividend Yield: N/A%
ROE: -43.17%
Latest News
-
Wells Fargo Maintains Overweight on Relay Therapeutics, Raises Price Target to $15
Fri, Feb 27, 2026 1:50 PM
-
12 Health Care Stocks Moving In Friday's Intraday Session
Fri, Feb 27, 2026 1:05 PM
-
Relay Therapeutics shares are trading higher after the company reported better-than-expected Q4 financial results.
Fri, Feb 27, 2026 11:43 AM
-
Relay Therapeutics Inc (NASDAQ:RLAY) Beats Q4 Revenue Estimates, Outlines Pivotal 2026 for Zovegalisib
Thu, Feb 26, 2026 11:37 PM
-
Relay Therapeutics Q4 Earnings Assessment
Thu, Feb 26, 2026 5:19 PM
-
Relay Therapeutics Q4 EPS $(0.32) Beats $(0.39) Estimate, Sales $7.000M Beat $4.966M Estimate
Thu, Feb 26, 2026 5:13 PM
-
Earnings Scheduled For February 26, 2026
Thu, Feb 26, 2026 7:11 AM
-
Relay Therapeutics Earnings Preview
Wed, Feb 25, 2026 4:01 PM
Key Financials
Financial data not available
